Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GILD Gilead Sciences Inc

96,84

1,25 (1,31%)

31 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Gilead Sciences Charts.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Gilead Sciences Charts.

News Gilead Sciences Inc

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications
Donnerstag 30 Januar 2025 (17 Stunden vor) • PR Newswire (US)

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025
Dienstag 28 Januar 2025 (2 Tage vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 15 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
Samstag 11 Januar 2025 (3 Wochen vor) • Business Wire

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 10 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 24 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 24 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Gilead Sciences to Present at Upcoming Investor Conference
Freitag 20 Dezember 2024 (1 Monat vor) • Business Wire

Weitere Gilead Sciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen